Background and aims: This review article was conducted for educational purposes to address a general overview of subclinical atherosclerosis, with the aim of reducing information bias with valid and reliable data around subclinical atherosclerosis with medical imaging perspectives around the carotid intima media. Methods: The steps summarizing the flowchart of information selection related to the use of engines providing English and French publications between 1997 and 2022 were followed. Results: The given results relevant to the history, morphology, atherogenesis, epidemioclinics (morbidity and mortality), anatomophysiology and morphopathology (circulating markers and biomarkers of endothelial damage, endothelium and structural markers, function of the endothelium, histopathological alterations, pathophysiology/ chronobiology/ atherogenesis, etiopathogeny of carotid atherosclerosis by medical imaging/ definition of complex interactions with cardiometabolic markers/mediators. Conclusion: Understanding the stages of atherosclerosis will enable the clinician and radiologist to improve the management of ischemic heart disease, stroke, and peripheral vascular pathology.
| Published in | Cardiology and Cardiovascular Research (Volume 6, Issue 2) |
| DOI | 10.11648/j.ccr.20220602.13 |
| Page(s) | 60-74 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Atherosclerosis, Medical Imaging, Carotid Intima Media
| [1] | Erbel R, Delaney JAC, Lehmann N, McClelland RL, Möhlenkamp S, Kronmal RA, et al. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J. 2008; 29 (22): 2782–2791. |
| [2] | Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Traffic. 2009; 119 (3): 382–389. |
| [3] | Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 2015; 65 (11): 1065–1074. |
| [4] | Gibson AO, Blaha MJ, Arnan MK, Sacco RL, Szklo M, Herrington DM, et al. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovascular Imaging. 2014; 7 (11): 1108–1115. |
| [5] | Martin SS, Blaha MJ, Blankstein R, Agatston A, Rivera JJ, Virani SS, et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Traffic. 2014; 129 (1): 77–86. |
| [6] | Zavodni AEH, Wasserman BA, McClelland RL, Gomes AS, Folsom AR, Polak JF, et al. Carotid artery plaque morphology and composition in relation to incident cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology. 2014; 271 (2): 381–389. |
| [7] | Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016; 118 (4): 535–546. |
| [8] | Bots ML, Evans GW, Tegeler CH, Meijer R. Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl). 2016; 129 (2): 215–226. |
| [9] | Boateng D, Agyemang C, Beune E, Meeks K, Smeeth L, Schulze MB, et al. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study. Int J Cardiol. 2018; 254: 310–315. |
| [10] | World Health Organization. WHO list of priority medical devices for management of cardiovascular diseases and diabetes. 2021. Geneva. World Health Organization https://apps.who.int/iris/handle/10665/341967. Accessed March 5, 2022. |
| [11] | Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Too Med Int Health. 2008; 13 (10): 1225–1234. |
| [12] | McGrath JC, Deighan C, Briones AM, Shafaroudi MM, McBride M, Adler J, et al. New aspects of vascular remodeling: the involvement of all vascular cell types. Exp Physiol. 2005; 90 (4): 469–475. |
| [13] | O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007; 50 (1): 1–13. |
| [14] | O'Rourke MF. Arterial aging: pathophysiological principles. Vasc Med. 2007; 12 (4): 329–341. |
| [15] | London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997; 51 (6): 1678–1695. |
| [16] | Kulshreshtha A, Goyal A, Veledar E, McClellan W, Judd S, Eufinger SC, et al. Association between ideal cardiovascular health and carotid intima-media thickness: a twin study. J Am Heart Assoc. 2014; 3 (1): e000282. |
| [17] | Polonsky TS, Ning H, Daviglus ML, Liu K, Burke GL, Cushman M, et al. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017; 6 (3): e004894. |
| [18] | Shpilsky D, Bambs C, Kip K, Patel S, Aiyer A, Olafiranye O, et al. Association between ideal cardiovascular health and markers of subclinical cardiovascular disease. Clin Cardiol. 2018; 41 (12): 1593–1599. |
| [19] | el-Barghouti N, Elkeles R, Nicolaides A, Geroulakos G, Dhanjil S, Diamond J. The ultrasonic evaluation of the carotid intima-media thickness and its relation to risk factors of atherosclerosis in normal and diabetic population. Int Angiol. 1997; 16 (1): 50–54. |
| [20] | Hwa C, Aird WC. The history of the capillary wall: doctors, discoveries, and debates. Am J Physiol Heart Circ Physiol. 2007; 293 (5): H2667-2679. |
| [21] | Creager M, Beckman J, Loscalzo. Vascular Medicine: A Companion to Braunwald's Heart Disease - 3rd Edition. https://www.elsevier.com/books/vascular-medicine-a-companion-to-braunwalds-heart-disease/creager/978-0-323-63600-1. Accessed March 2, 2022. |
| [22] | Libby P. The Pathogenesis, Prevention, and Treatment of Atherosclerosis | Harrison's Principles of Internal Medicine, 19th | Access Pharmacy | McGraw Hill Medical. Harrison's Principles of Internal Medicine, 19th. 2015 https://accesspharmacy.mhmedical.com/content.aspx?bookid=1130§ionid=79743366. Accessed March 2, 2022. |
| [23] | Dubreuil E. Diet and atherosclerosis. 2013; not specified. |
| [24] | Dajnowiec D, Langille BL. Arterial adaptations to chronic changes in haemodynamic function: coupling vasomotor tone to structural remodeling. Clin Sci (London). 2007; 113 (1): 15–23. |
| [25] | World Health Organization. Cardiovascular diseases (CVDs). 2017. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases- (cvds). Accessed March 2, 2022. |
| [26] | Mbewu A, Mbanya JC. Cardiovascular Disease in Disease and Mortality in Sub-Saharan Africa. In CVD in Africa,. 2nd ed. 2006. Washington (DC). World Bank. |
| [27] | Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021; 398 (10304): 957–980. |
| [28] | Professor Jean-Jacques Mourad. Calculate the age of your arteries. French committee for the fight against arterial hypertension.. |
| [29] | Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health. 2009; 5 (1): 9. |
| [30] | Belue R, Okonor T, Iwelunmor J, Taylor K, Degboe A, Agyemang C, et al. An overview of cardiovascular risk factor burden disease o-morbidity between infectious disease and chronic disease in sub-Saharan African countries: a socio-cultural perspective. 5: 10. |
| [31] | Wood D, Joint European Societies Task Force. Established and emerging cardiovascular risk factors. Am Heart J. 2001; 141 (2 Suppl): S49-57. |
| [32] | Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens. 2004; 18 (1): 17–23. |
| [33] | Herinirina NF, Rajaonarison LHNON, Herijoelison AR, Ahmad A. Carotid intima-media thickness and cardiovascular risk factors. The Pan African Medical Journal. 2015; 21 (153). doi: 10.11604/pamj.2015.21.153.6876. |
| [34] | Businge CB, Longo-Mbenza B, Adeniyi OV, Muaka MM, Lelo GM, Nkanga MSN, et al. Diagnostic performance of several biomarkers for identification of cases of non-communicable diseases among Central Africans. Afr Health Sci. 2018; 18 (4): 909–916. |
| [35] | Talari HR, Moniri R, Mollaghanbari M, Haddad Kashani H, Jalalian MN. Evaluating the relationship between Helicobacter pylori infection and carotid intima-media thickness a cross sectional study. Ann Med Surg (London). 2021; 69: 102659. |
| [36] | World Health Organization. Regional Office for the Eastern Mediterranean. List of basic sources in English for a medical faculty library. 2008. https://apps.who.int/iris/handle/10665/119878. Accessed March 5, 2022. |
| [37] | BZ, PP, Ga M, M E. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature reviews Cardiology. 2021; 18 (11). doi: 10.1038/s41569-021-00559-8. |
| [38] | Blacher J, Olié V. Hypertension and renal disease: a relationship under close surveillance. The kidney disease patient magazine. 2020; 35. |
| [39] | Delisle H, Faber M, Revault P. Evidence-based strategies needed to combat malnutrition in Sub-Saharan countries facing different stages of nutrition transition. Public Health Nutr. 24 (12): 3577–3580. |
| [40] | Lofandjola Masumbuku J, Sumaili Kiswaya E, Mairiaux P, Gillain D, Petermans J. Chronic illness needing palliative care in Kinshasa hospitals, Democratic Republic of the Congo (DRC). Too Med Health. 2017; 45: 11. |
| [41] | Vandeputte M. coronary atherosclerosis in Congolese. 1958. |
| [42] | Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F, et al. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovascular Prev Rehabil. 2008; 15 (5): 503–508. |
| [43] | Tshiani K, Musuamba M. Epidemiology of arterial hypertension in Zaire. Results of a preliminary survey in 4988 subjects. Med Afr Noire. 1979; 26: 65–75. |
| [44] | M'Buyamba-Kabangu J, Disashi T, Kayembe PK, Buila N, Lepira FB. Pulse pressure, renal function and mortality in hospitalized Congolese patients with arterial hypertension. African annals of medicine. 2009; 2 (3): 231–239. |
| [45] | Lepira F, Kayembe P, M'buyamba-Kabangu J, Nseka M. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension. Cardiovascular journal of South Africa: official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners. 2006. |
| [46] | Atoba B, Kayembe T, Batina A, Mbo M, Ngandu W, Tsongo K, et al. Prevalence, knowledge and degree of control of arterial hypertension in Kisangani, DR Congo. Medical journal of research information and medical education. 2004; 5 (2): 86–93. |
| [47] | Ngombe LK, Cowgill K, Monga BB, Ilunga BK, Stanis WO, Numbi OL. Prevalence of arterial hypertension in the population of millers in the city of Lubumbashi, Democratic Republic of Congo. Pan Afr Med J. 2015; 22: 152. |
| [48] | M'Buyamba-Kabangu JR, Biswika RT, Thijs L, Tshimanga GM, Ngalula FM, Disashi T, et al. In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens. 2009; 22 (6): 643–648. |
| [49] | Mathers CD, Lopez AD, Murray CJL. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global Burden of Disease and Risk Factors. 2006. Washington (DC). World Bank http://www.ncbi.nlm.nih.gov/books/NBK11808/. Accessed March 5, 2022. |
| [50] | Organization Mundial de la Salud. Genero, climatic and healthy climate. 2016. Ginebra. Organization Mundial de la Salud https://apps.who.int/iris/handle/10665/204178. Accessed March 5, 2022. |
| [51] | Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007; 21 (3): 157–171. |
| [52] | Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood. 1999; 93 (9): 2951–2958. |
| [53] | Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood. 2005; 105 (7): 2783–2786. |
| [54] | Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992; 326 (4): 242–250. |
| [55] | Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002; 34 (12): 1508–1512. |
| [56] | Mauge L. Physiology of the circulating endothelial compartment in pulmonary arterial hypertension and prospects for the development of a cell therapy product. 201. |
| [57] | Lucano M. Role of the endothelial cell in atherosclerosis. 1997; 187. |
| [58] | Broze GJ, Girard TJ. TISSUE FACTOR PATHWAY INHIBITOR: STRUCTURE-FUNCTION. Front Biosci. 2012; 17: 262–280. |
| [59] | Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998; 91 (10): 3527–3561. |
| [60] | Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003; 31 (4 Suppl): S221-230. |
| [61] | Cohen A. Cardiology and vascular pathology - Ariel Cohen - Librairie Eyrolles. 1997 https://www.eyrolles.com/Sciences/Livre/cardiologie-et-pathologie-vascular-9782909455679/. Accessed March 5, 2022. |
| [62] | Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014; 114 (12): 1852–1866. |
| [63] | Louis AJ. Atherosclerosis. Nature. 2000; 407 (6801): 233–241. |
| [64] | Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002; 16 (11): 1348–1360. |
| [65] | Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Traffic. 1963; 27: 929–934. |
| [66] | Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D, et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci. 2015; 52 (2): 70–85. |
| [67] | Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Traffic. 2011; 123 (20): 2292–2333. |
| [68] | Paul JL, Baudin B. Pathophysiology of atherosclerosis and early markers. Francophone Journal Of Laboratories. 2009; 2009: 41–50. |
| [69] | Chronobiology Inserm, Science for health. Inserm. https://www.inserm.fr/dossier/chronobiologie/. Accessed March 5, 2022. |
| [70] | Sánchez A, Calpena AC, Clares B. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci. 2015; 16 (8): 16981–17004. |
| [71] | de Jaeger C. Physiologie du vieillissement. EMC - Kinésithérapie-Médecine physique-Réadaptation 2018; 14 (1): 1-11. |
| [72] | Cottart. biology of aging and arteriosclerosis. 2009; 3: 22. |
| [73] | Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Traffic. 2018; 137 (12): e67–e492. |
| [74] | Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994; 330 (20): 1431–1438. |
| [75] | Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989; 13 (6 Pt 2): 968–972. |
| [76] | Edward. Back To Physio: The blood pressure curve. 2016; 10. |
| [77] | Lehoux S, Castier Y, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med. 2006; 259 (4): 381–392. |
| [78] | Califano JP, Reinhart-King CA. Exogenous and endogenous force regulation of endothelial cell behavior. J Biomech. 2010; 43 (1): 79–86. |
| [79] | Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W, Richardson M, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Traffic. 1992; 85 (1): 391–405. |
| [80] | Humphrey JD. Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress. Hypertension. 2008; 52 (2): 195–200. |
| [81] | Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Traffic. 1994; 89 (6): 2888–2891. |
| [82] | Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg. 1987; 5 (3): 413–420. |
| [83] | Cummins PM, von Offenberg Sweeney N, Killeen MT, Birney YA, Redmond EM, Cahill PA. Cyclic strain-mediated matrix metalloproteinase regulation within the vascularendothelium: a force to be reckoned with. Am J Physiol Heart Circ Physiol. 2007; 292 (1): H28-42. |
| [84] | Iba T, Sumpio BE. Morphological response of human endothelial cells subjected to cyclic strain in vitro. Microvasc Res. 1991; 42 (3): 245–254. |
| [85] | Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011; 91 (1): 327–387. |
| [86] | Samady H, Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Maynard C, et al. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Traffic. 2011; 124 (7): 779–788. |
| [87] | Fukumoto Y, Hiro T, Fujii T, Hashimoto G, Fujimura T, Yamada J, et al. Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution. J Am Coll Cardiol. 2008; 51 (6): 645–650. |
| [88] | White SJ, Hayes EM, Lehoux S, Jeremy JY, Horrevoets AJG, Newby AC. Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. J Cell Physiol. 2011; 226 (11): 2841–2848. |
| [89] | Slager CJ, Wentzel JJ, Gijsen FJH, Thury A, van der Wal AC, Schaar JA, et al. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovascular Med. 2005; 2 (9): 456–464. |
| [90] | Stone PH, Saito S, Takahashi S, Makita Y, Nakamura S, Kawasaki T, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Traffic. 2012; 126 (2): 172–181. |
| [91] | Loscalzo J, Libby P, Epstein JA. Basic Biology of the Cardiovascular System. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 2014. New York, NY. McGraw-Hill Education accessmedicine.mhmedical.com/content.aspx?aid=1120804333. Accessed March 5, 2022. |
| [92] | Chistiakov DA, Orekhov AN, Bobryshev YV. Effects of shear stress on endothelial cells: go with the flow. Acta Physiol (Oxf). 2017; 219 (2): 382–408. |
| [93] | Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007; 49 (25): 2379–2393. |
| [94] | Ginsberg HN. Lipoprotein physiology. Endocrinol Metab Clin North Am. 1998; 27 (3): 503–519. |
| [95] | Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol. 2007; 27 (5): 986–989. |
| [96] | Kolodgie FD, Burke AP, Wight TN, Virmani R. The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture. Curr Opin Lipidol. 2004; 15 (5): 575–582. |
| [97] | Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32 (9): 2045–2051. |
| [98] | Mi C, Ma G. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (New York, NY). 1991; 251 (4995). doi: 10.1126/science.1990440. |
| [99] | Nakashima Y, Wight T, Sueishi K. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovascularresearch. 2008; 79 (1). doi: 10.1093/cvr/cvn099. |
| [100] | Hunt KJ, Sharrett AR, Chambless LE, Folsom AR, Evans GW, Heiss G. Acoustic shadowing on B-mode ultrasound of the carotid artery predicts CHD. Ultrasound Med Biol. 2001; 27 (3): 357–365. |
| [101] | National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Traffic. 2002; 106 (25): 3143–3421. |
| [102] | Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000; 151 (5): 478–487. |
| [103] | Chambless L, Heiss G, Folsom A, Rosamond W, Szklo M, Sharrett A, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997; 146 (6). doi: 10.1093/oxfordjournals.aje.a009302. |
| [104] | van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DAM, Witteman JCM. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Traffic. 2004; 109 (9): 1089–1094. |
| [105] | Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Traffic. 2000; 101 (1): E16-22. |
| [106] | Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr. 2006; 19 (8): 943–954. |
| [107] | Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging andIntervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Traffic. 2006; 114 (16): 1761–1791. |
| [108] | Brindle PM, McConnachie A, Upton MN, Hart CL, Smith GD, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract. 2005; 55 (520): 838–845. |
| [109] | Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Traffic. 1998; 97 (15): 1467–1473. |
| [110] | Okeahialam BN, Alonge BA, Pam SD, Puepet FH. Carotid Intima Media Thickness as a Measure of Cardiovascular Disease Burden in Nigerian Africans with Hypertension and Diabetes Mellitus. Int J Vasc Med. 2011; 2011: 327171. |
| [111] | Booth GL, Kapral MK, Fung K, Tu JV. Relationship between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368 (9529): 29–36. |
| [112] | Sierra C, de la Sierra A. Early detection and management of the high-risk patient with elevated blood pressure. Vasc Health Risk Manag. 2008; 4 (2): 289–296. |
| [113] | Bounhoure JP. Heart failure and kidney failure: a growing problem!2006; 5. |
| [114] | Lee CJ, Park S. The role of carotid ultrasound for cardiovascular risk stratification beyond traditional risk factors. Yonsei Med J. 2014; 55 (3): 551–557. |
| [115] | Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011; 365 (3): 213–221. |
| [116] | Mayosi BM, Somers K. Cardiomyopathy in Africa: heredity versus environment. Cardiovascular J Afr. 2007; 18 (3): 175–179. |
| [117] | Isaza C, de Seigneux S. Proteinuria: physiological reminder and practical applications. 7. |
APA Style
Yanda Tongo Stéphane, Longo-Mbenza Benjamin, Lelo Tshikwela Michel, Makulo Risasi Jean Robert, Molua Aundu Antoine, et al. (2022). Critical Review of Subclinical Atherosclerosis: Perspectives on Medical Imaging Around the Carotid Intima Media. Cardiology and Cardiovascular Research, 6(2), 60-74. https://doi.org/10.11648/j.ccr.20220602.13
ACS Style
Yanda Tongo Stéphane; Longo-Mbenza Benjamin; Lelo Tshikwela Michel; Makulo Risasi Jean Robert; Molua Aundu Antoine, et al. Critical Review of Subclinical Atherosclerosis: Perspectives on Medical Imaging Around the Carotid Intima Media. Cardiol. Cardiovasc. Res. 2022, 6(2), 60-74. doi: 10.11648/j.ccr.20220602.13
AMA Style
Yanda Tongo Stéphane, Longo-Mbenza Benjamin, Lelo Tshikwela Michel, Makulo Risasi Jean Robert, Molua Aundu Antoine, et al. Critical Review of Subclinical Atherosclerosis: Perspectives on Medical Imaging Around the Carotid Intima Media. Cardiol Cardiovasc Res. 2022;6(2):60-74. doi: 10.11648/j.ccr.20220602.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ccr.20220602.13,
author = {Yanda Tongo Stéphane and Longo-Mbenza Benjamin and Lelo Tshikwela Michel and Makulo Risasi Jean Robert and Molua Aundu Antoine and Kisoka Lusunsi Christian and Mawalala Malengele Héritier and Monkondjimobe Etienne},
title = {Critical Review of Subclinical Atherosclerosis: Perspectives on Medical Imaging Around the Carotid Intima Media},
journal = {Cardiology and Cardiovascular Research},
volume = {6},
number = {2},
pages = {60-74},
doi = {10.11648/j.ccr.20220602.13},
url = {https://doi.org/10.11648/j.ccr.20220602.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20220602.13},
abstract = {Background and aims: This review article was conducted for educational purposes to address a general overview of subclinical atherosclerosis, with the aim of reducing information bias with valid and reliable data around subclinical atherosclerosis with medical imaging perspectives around the carotid intima media. Methods: The steps summarizing the flowchart of information selection related to the use of engines providing English and French publications between 1997 and 2022 were followed. Results: The given results relevant to the history, morphology, atherogenesis, epidemioclinics (morbidity and mortality), anatomophysiology and morphopathology (circulating markers and biomarkers of endothelial damage, endothelium and structural markers, function of the endothelium, histopathological alterations, pathophysiology/ chronobiology/ atherogenesis, etiopathogeny of carotid atherosclerosis by medical imaging/ definition of complex interactions with cardiometabolic markers/mediators. Conclusion: Understanding the stages of atherosclerosis will enable the clinician and radiologist to improve the management of ischemic heart disease, stroke, and peripheral vascular pathology.},
year = {2022}
}
TY - JOUR T1 - Critical Review of Subclinical Atherosclerosis: Perspectives on Medical Imaging Around the Carotid Intima Media AU - Yanda Tongo Stéphane AU - Longo-Mbenza Benjamin AU - Lelo Tshikwela Michel AU - Makulo Risasi Jean Robert AU - Molua Aundu Antoine AU - Kisoka Lusunsi Christian AU - Mawalala Malengele Héritier AU - Monkondjimobe Etienne Y1 - 2022/05/12 PY - 2022 N1 - https://doi.org/10.11648/j.ccr.20220602.13 DO - 10.11648/j.ccr.20220602.13 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 60 EP - 74 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20220602.13 AB - Background and aims: This review article was conducted for educational purposes to address a general overview of subclinical atherosclerosis, with the aim of reducing information bias with valid and reliable data around subclinical atherosclerosis with medical imaging perspectives around the carotid intima media. Methods: The steps summarizing the flowchart of information selection related to the use of engines providing English and French publications between 1997 and 2022 were followed. Results: The given results relevant to the history, morphology, atherogenesis, epidemioclinics (morbidity and mortality), anatomophysiology and morphopathology (circulating markers and biomarkers of endothelial damage, endothelium and structural markers, function of the endothelium, histopathological alterations, pathophysiology/ chronobiology/ atherogenesis, etiopathogeny of carotid atherosclerosis by medical imaging/ definition of complex interactions with cardiometabolic markers/mediators. Conclusion: Understanding the stages of atherosclerosis will enable the clinician and radiologist to improve the management of ischemic heart disease, stroke, and peripheral vascular pathology. VL - 6 IS - 2 ER -
Information
Email: